Antithrombin III Activity with Reflex to Antithrombin III Antigen

Test Code
8267N


CPT Codes
85300

Includes
If Antithrombin III Activity is below reference interval, then Antithrombin III Antigen will be performed at an additional charge (CPT code(s): 85301).


Preferred Specimen
1 mL frozen platelet-poor plasma collected in each of two 3.2% sodium citrate (light blue-top) tubes


Minimum Volume
0.5 mL each specimen


Instructions
Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collections. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and transport on dry ice.


Transport Temperature
Frozen


Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric


Methodology
Chromogenic Substrate

Setup Schedule
P.M.


Limitations
Falsely elevated results may be caused by heparin cofactor II.


Clinical Significance
Aids in characterization of Antithrombin deficiency (AT, previously referred to as Antithrombin III) which is associated with increased thrombotic risk. Type I deficiency is characterized by reduction in activity and antigen levels simultaneously. With type II deficiency, activity levels are lower in comparison to the antigen levels (dysfunctional protein). Acquired deficiency, more common than inherited defects, can occur due to: liver disease, nephrotic syndrome, heparin therapy, disseminated intra- vascular coagulation (DIC), sepsis, and L-asparaginase chemotherapy.

Anticoagulant Interference: Expected impact by therapeutic levels (potential interference depends upon drug concentration): Warfarin: no effect; Heparin (UFH or LMWH): no effect to decrease (UFH may decrease levels physiologically but no assay interference); Dabigatran or Argatroban (Thrombin Inhibitors): may falsely increase activity levels; Rivaroxaban, Apixaban, Edoxaban (Factor Xa Inhibitors): no effect.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.